Antibiotic Treatment for Infected Abscess with MRSA Coverage

Introduction to MRSA Treatment

The American College of Physicians recommends incision and drainage as the cornerstone of treatment for infected abscesses, with trimethoprim-sulfamethoxazole (TMP-SMX) as the preferred first-line oral antibiotic for outpatient management, at a dose of 1-2 double-strength tablets twice daily for 5-10 days 1, 2
The Infectious Diseases Society of America suggests that incision and drainage is mandatory for all abscesses, and antibiotics alone are insufficient for abscess treatment 2

Obtaining cultures from purulent drainage before starting antibiotics is crucial to confirm MRSA and guide therapy, according to the Centers for Disease Control and Prevention 2
The Society of Surgical Oncology recommends that patients with systemic signs of infection, rapidly progressive infection, multiple sites of infection, abscess in difficult-to-drain locations, septic phlebitis, or significant comorbidities should be admitted to the hospital 1

The American Academy of Family Physicians recommends TMP-SMX 1-2 double-strength tablets twice daily as the preferred first-line oral antibiotic for MRSA skin and soft tissue infections, including abscesses, due to its high clinical effectiveness in MRSA-prevalent settings 1, 2
Doxycycline 100 mg twice daily or minocycline 200 mg loading dose followed by 100 mg twice daily are equally effective alternatives to TMP-SMX, according to the American College of Physicians 1, 2
Clindamycin 300-450 mg three times daily provides dual coverage for both MRSA and β-hemolytic streptococci, but should only be used if local MRSA resistance rates are below 10% due to concerns about inducible resistance, as recommended by the Infectious Diseases Society of America 1, 2

Vancomycin 15-20 mg/kg IV every 8-12 hours is the gold standard for hospitalized patients requiring MRSA coverage, according to the Society of Healthcare Epidemiology of America 1
Alternative IV options when vancomycin cannot be used include linezolid 600 mg IV twice daily, daptomycin 4 mg/kg IV once daily, or clindamycin 600 mg IV three times daily if local resistance is low, as recommended by the American College of Chest Physicians 1
For severe infections with systemic toxicity requiring coverage of both MRSA and streptococci, vancomycin plus piperacillin-tazobactam or imipenem-meropenem should be used, according to the Infectious Diseases Society of America 3, 1

The standard duration of treatment is 5-10 days for uncomplicated MRSA skin infections after adequate drainage, as recommended by the American Academy of Dermatology 3, 2
Extend treatment to 7-14 days for more severe or complicated cases based on clinical response, according to the Society of Infectious Diseases Pharmacists 2
MRSA coverage is mandatory when the abscess is associated with penetrating trauma, evidence of MRSA infection elsewhere or prior MRSA colonization, injection drug use, purulent drainage, or systemic inflammatory response syndrome (SIRS), as recommended by the Centers for Disease Control and Prevention 1

For recurrent abscesses at the same site, search for local causes such as pilonidal cyst, hidradenitis suppurativa, or foreign material, according to the American College of Surgeons 3
Culture recurrent abscesses early and treat with a 5-10 day course of an antibiotic active against the pathogen isolated, as recommended by the Infectious Diseases Society of America 3
Never use β-lactam antibiotics alone when MRSA is suspected or confirmed, as they have no activity against methicillin-resistant organisms, according to the American College of Physicians 1, 2
Failure to adequately drain abscesses leads to treatment failure regardless of antibiotic choice, as recommended by the Society of Surgical Oncology 2